100 Participants Needed

Self-Management Program for Stroke

(IPASS-R Trial)

AE
JH
Overseen ByJuliana H. Earwood, OTD, OTR/L
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Missouri-Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Improving Participation after Stroke Self-Management Program (IPASS)?

Research shows that self-management programs can improve quality of life and self-confidence in managing health for stroke survivors. The IPASS program specifically aims to enhance participation in daily activities, which is crucial for long-term recovery and community reintegration after a stroke.12345

Is the Self-Management Program for Stroke safe for humans?

The available research does not specifically address the safety of the Self-Management Program for Stroke, but self-management programs in general are designed to support stroke survivors in managing their health and medications, which suggests they are generally safe and focused on improving quality of life.13678

How is the IPASS treatment different from other stroke treatments?

The IPASS treatment is unique because it focuses on improving participation in everyday life activities and community reintegration for stroke survivors, rather than just managing symptoms. It is a self-management program that enhances self-efficacy (confidence in managing one's condition) and is delivered in a group setting led by an occupational therapist and a lay person with stroke experience.1591011

Research Team

AE

Anna E Boone, PhD, OTR/L

Principal Investigator

University of Missouri Occupational Therapy

Eligibility Criteria

This trial is for individuals aged 45-85 who had a mild or moderate stroke within the last 6 months, live in the community (not in skilled nursing facilities), can communicate in English, and can use videoconferencing with or without help. They should have finished any recommended inpatient rehab.

Inclusion Criteria

I live at home, with or without help from a caregiver.
I had a stroke less than 6 months ago.
I can use video calls on my own or with help.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the IPASS-R intervention consisting of 6 weekly 90-minute sessions delivered via telehealth

6 weeks
6 visits (virtual)

Follow-up

Participants are monitored for self-efficacy, activity performance, and quality of life improvements

26 weeks
1 visit (virtual) at 6-month follow-up

Treatment Details

Interventions

  • Improving Participation after Stroke Self-Management Program (IPASS)
Trial Overview The study tests a telehealth program called IPASS designed specifically for stroke survivors to improve self-confidence, daily activities, and life quality after stroke. It's compared to a general chronic disease program known as CDSMP.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Improving Participation after Stroke Self-Management Program (IPASS)Experimental Treatment1 Intervention
The IPASS-R intervention consists of 6 weekly 90-minute sessions delivered by an occupational therapist and stroke survivor peer facilitator. All sessions will be delivered remotely via videoconferencing.
Group II: Chronic Disease Self-Management Program (CDSMP)Active Control1 Intervention
The CDSMP will consist of 6, weekly 90-minute sessions. All sessions will be delivered remotely via videoconferencing.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Missouri-Columbia

Lead Sponsor

Trials
387
Recruited
629,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

University of Washington

Collaborator

Trials
1,858
Recruited
2,023,000+

University of Illinois at Chicago

Collaborator

Trials
653
Recruited
1,574,000+

Findings from Research

Only 29% of stroke survivors participated in the Chronic Disease Self-Management Program (CDSMP), but participation increased when barriers like transportation and financial issues were addressed.
Factors such as moderate to severe disability and more frequent clinic/home visits were linked to higher attendance in CDSMP sessions, suggesting that tailored support can enhance engagement in self-management programs.
Factors Associated With Participation in the Chronic Disease Self-Management Program: Findings From the SUCCEED Trial.Lin, AM., Vickrey, BG., Barry, F., et al.[2022]
The Southampton Stroke Self-Management Questionnaire (SSSMQ) was developed and tested with 87 stroke survivors, showing excellent reliability (Mokken r = 0.89) and test-retest reliability (ICC = 0.928).
Preliminary results indicate that the SSSMQ is a valid tool for measuring self-management competency in stroke patients, making it a promising outcome measure for evaluating self-management interventions.
Development and psychometric evaluation of a new patient -reported outcome measure for stroke self -management: The Southampton Stroke Self - Management Questionnaire (SSSMQ).Boger, EJ., Hankins, M., Demain, SH., et al.[2022]
The Stroke Self-management Behaviors Performance Scale (SSBPS) was developed and validated with 128 stroke survivors, showing good internal consistency and test-retest reliability, indicating it is a reliable tool for assessing self-management behaviors in stroke recovery.
The SSBPS identified two key factors—'Psychosocial management' and 'Medical management'—which together accounted for 62% of the variance, suggesting that both aspects are crucial for effective self-management in stroke survivors.
Development and psychometric evaluation of a questionnaire for assessing self-management behaviors in stroke survivors.Lo, SHS., Chau, JPC., Choi, KC.[2022]

References

Factors Associated With Participation in the Chronic Disease Self-Management Program: Findings From the SUCCEED Trial. [2022]
Development and psychometric evaluation of a new patient -reported outcome measure for stroke self -management: The Southampton Stroke Self - Management Questionnaire (SSSMQ). [2022]
Development and psychometric evaluation of a questionnaire for assessing self-management behaviors in stroke survivors. [2022]
Longitudinal Study of Effectiveness of a Patient-Centered Self-Management Empowerment Intervention During Predischarge Planning on Stroke Survivors. [2022]
The Development of the Improving Participation after Stroke Self-Management Program (IPASS): An Exploratory Randomized Clinical Study. [2019]
Medication self-management interventions for persons with stroke: A scoping review. [2023]
Experiences of Self-Management Support Following a Stroke: A Meta-Review of Qualitative Systematic Reviews. [2022]
The Look After Yourself (LAY) intervention to improve self-management in stroke survivors: Results from a quasi-experimental study. [2021]
Examining the feasibility and effectiveness of a culturally adapted participation-focused stroke self-management program in a day-rehabilitation setting: A randomized pilot study. [2021]
Examining a participation-focused stroke self-management intervention in a day rehabilitation setting: a quasi-experimental pilot study. [2018]
Self-management programmes for people post stroke: a systematic review. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security